Solterra Renewable Technologies, Inc., a solar technology and quantum dot manufacturing company (and a wholly owned subsidiary of Hague Corp. (OTC Bulletin Board: HGUE)) announced today that only 18 months after licensing what has been characterized as a disruptive technology, they will be offering incentive pricing on orders for research quantities of its high purity, uniform, tetrapod quantum dots from the life sciences, academic, and other industrial research and development (R&D) communities.
Tetrapod quantum dots have been recognized for their superior performance in a wide variety of current and future applications. These include, biology and biomedicine; computing and memory; electronics and displays; optoelectronic devices such as solar cells, LEDs, lighting, and lasers; optical components used in telecommunications; and security applications such as covert identification tagging or biowarfare detection sensors.
We believe that our tetrapod quantum dots are truly an enabling technological break through. As such we have an obligation to make sure these materials are accessible to researchers across the globe so discovery in the advanced electronics and life sciences fields, among others, can be realized and accelerated.
Offering the tetrapod quantum dots at a substantial cost savings will allow the product to be much more accessible to an ever widening range of research. There are a number of potential applications for quantum dots that have not been well described and we really believe this is going to be the kind of platform technology that spurs innovation and creativity throughout the scientific community. Said Stephen B. Squires, CEO and President of Solterra/Hague.
According to David Doderer VP R&D Solterra's tetrapod quantum dots are produced using the Rice University licensed process technology that delivers high purity, uniform tetrapod quantum dots ideally suited for a broad range of applications and more specifically can produce these quantum dots at a price point that can transform these technologies into commercially viable solution driven products.
According to a report available at Electronics.ca Publications, the global market for QDs, which in 2008 was estimated to generate $28.6 million in revenues, is projected to grow over the next 5 years at a compound annual growth rate (CAGR) of 90.7%, reaching over $700 million by 2013. Following the initially modest revenues generated by standalone colloidal QDs - primarily serving the life sciences, academic, and other industrial research and development (R&D) communities - within the next 2 years several product launches with colloidal or in situ QD underpinning will bolster market revenue considerably.